Neuromuscular manifestations of endocrine disorders

Neurologic Clinics

Volumn 20, Issue 1, 2002, Pages 35-58

  Alshekhlee, Amer ^a   Kaminski, Henry J ^a   Ruff, Robert L ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; BETAMETHASONE; BROMOCRIPTINE; CALCIUM; CORTICOSTEROID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; ELECTROLYTE; FLUORINATED STEROID; GLUCOCORTICOID; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; LIOTHYRONINE; MAGNESIUM; MINERALOCORTICOID; MUSCLE ENZYME; PARATHYROID HORMONE; PROPRANOLOL; SOMATOMEDIN C; STEROID; THYROID HORMONE; THYROTROPIN; THYROXINE; TRIAMCINOLONE; VITAMIN D;

ACROMEGALY; ADRENAL INSUFFICIENCY; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ELECTRODIAGNOSIS; ENDOCRINE DISEASE; GRAVES DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERPARATHYROIDISM; HYPERTHYROIDISM; HYPOPARATHYROIDISM; HYPOPHYSIS DISEASE; HYPOPITUITARISM; HYPOTHYROIDISM; KIDNEY FAILURE; METABOLIC BONE DISEASE; NEUROMUSCULAR DISEASE; OSTEOMALACIA; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TETANY;

EID: 0036154682     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(03)00053-7     Document Type: Review

References (132)

1. Clinical characteristics of children with hypoparathyroidism due to 22q11.2 microdeletion
2. Inhaled and systemic corticosteroid therapies: Do they contribute to inspiratory muscle weakness in asthma?
3. Fiber-type discrimination in disuse and glucocorticoid-induced atrophy
4. Effects of thyroid hormones on skeletal muscle bioenergetics. In vivo phosphorus-31 magnetic resonance spectroscopy study of humans and rats
5. Multiple endocrine involvement in two pediatric patients with Kearns-Sayre syndrome
6. Steroid myopathy in connective tissue disease
7. Effect of parathyroid hormone on energy metabolism of skeletal muscle
8. Pathogenesis of Graves ophthalmopathy
9. A synergistic effect of glucocorticoids and insulin on the differentiation of myoblasts
10. Dialysis myopathy. Report of 13 cases
11. Glucocorticoid hormone action
12. Steroid hormone receptors: An update
13. Rhabdomyolysis in thyroid storm
14. Chronic renal failure presenting as proximal muscle weakness in a child
15. Dexamethasone markedly induces Na,K-ATPase messenger RNA beta-1 in a rat liver cell line
16. Influence of growth hormone on the protein composition of rat muscle
17. 25-Hydroxycholecalciferol stimulation of muscle metabolism
18. Mitochondrial DNA deletion with Kearns Sayre syndrome in a child with Addison disease
19. Impairment of cardiac function and bioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene
20. Resistance exercise prevents glucocorticoid-induced myopathy in heart transplant recipients
21. Azathioprine with prednisone for polymyositis: A controlled, clinical trial
22. Effect of hyperthyroidism on fibre-type composition, fibre area, glycogen content and enzyme activity in human skeletal muscle
23. Myopathy in primary familial hyperparathyroidism. Clinical and morphological studies
24. Neuromuscular recovery after parathyroidectomy in primary hyperparathyroidism
25. Effects of altered thyroid status on beta-adrenergic actions on skeletal muscle glycogen metabolism
26. Growth hormone deficiency disorders
27. Effects of chronic renal failure on enzymes of energy metabolism in individual human muscle fibers
28. Basophilic adenomas of the pituitary body and their clinical manifestations
29. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes
30. Normocalcemic tetany abolished by calcium infusion
31. Neuromuscular symptoms in elderly patients with hyperparathyroidism: Improvement with parathyroid surgery
32. Muscular performance and fatigue in primary hyperparathyroidism
33. Mitochondrial myopathies
34. Sensitivity of the soleus muscle to insulin in resting and exercising with experimental hypo- and hyperthyroidism
35. Disuse atrophy of skeletal muscle is associated with an increase in number of glucocorticoid receptors
36. Myasthenia gravis associated with adrenocortical insufficiency. Report of two cases
37. Neuromuscular findings in thyroid dysfunction: A prospective clinical and electrodiagnostic study
38. Thyroid thermogenesis
39. Electron microscopic observations in thyrotoxic and corticosteroid myopathies
40. Central changes in hypothyroid myopathy: A case report
41. Na(+)-K+ pump in rat muscle: Effects of hypophysectomy, growth hormone, and thyroid hormone
42. Effects of the somatomedins and insulin on myoblast differentiation in vivo
43. Glucocorticoid-induced muscle atrophy prevention by exercise in fast-twitch fibers
44. Magnesium deficiency: Etiology and clinical spectrum
45. Skeletal muscle fiber types and myosin ATPase activity do not change with age or growth hormone administration
46. Myopathy in chronic renal failure
47. Autoimmune thyroiditis and myopathy. Reversibility of myopathic alterations under thyroxine therapy
48. Effects of parathyroid hormone on skeletal muscle protein and amino acid metabolism in the rat
49. Adrenal glucocorticoid permissive regulation of muscle glycogenolysis: Action of protein phosphatase(s) and its inhibitor(s)
50. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients
51. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement
52. Acute type II myofiber atrophy in critical illness
53. Inflammatory myopathy in thyrotoxicosis
54. Electromyographic and histological findings in the muscles of patients with thyrotoxicosis
55. Effects of 1,25-dihydroxycholecalciferon on calcium absorption, muscle weakness, and bone disease in chronic renal failure
56. Firing patterns of motor units in normal rats
57. Glucocorticoid antagonism by exercise and adrenergic-anabolic steroids
58. A clinical and electrophysiological evaluation
59. The acromegalic rosary
60. Electromyography in nutritional osteomalacic myopathy
61. Hypocalcemic hyper-CK-emia in hypoparathyroidism
62. Primary hyperparathyroidism and ALS: Is there a relation?
63. Dysthyroid orbitopathy
64. Effect of thyroid hormone on the myosin heavy chain isoforms in slow and fast muscles of the rat
65. Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency
66. Role of glucocorticoids in the response of rat leg muscles to reduced activity
67. Endocrine myopathies. (Hyper- and hypofunction of adrenal, thyroid, pituitary, and parathyroid glands and iatrogenic corticosteroid myopathy.)
68. Acute steroid-induced tetraplegia following status asthmaticus
69. Effect of treatment on skeletal muscle dysfunction in hypothyroidism
70. The neuromuscular features of acromegaly: A clinical and pathological study
71. Thyroid function and circulating antithyroid antibodies in myasthenia gravis
72. Resolution of abnormal muscle enzyme studies in hypothyroidism
73. Thyroid(neuro)myopathy
74. The biology of growth hormone
75. Acute myopathy of intensive care: Clinical, electromyographic, and pathological aspects
76. Glucocorticoid-induced muscle atrophy. The role of exercise in treatment and prevention
77. Diaphragm strength and cross-bridge properties during chronic growth hormone hypersecretion
78. High muscle lipoprotein lipase activity in thyrotoxic patients
79. Neuromuscular involvement in primary hyperparathyroidism
80. Growth hormone and cardiac function
81. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA
82. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes
83. Hypothyrodism. A reversible cause of diaphragmatic dysfunction
84. Respiratory muscle weakness and dyspnea in thyrotoxic patients
85. Has the target autoantigen for Graves' ophthalmopathy been found?
86. Respiratory muscle weakness in Addison's disease
87. The role of insulin and other hormones in the regulation of amino acid and protein metabolism in humans
88. Severe hypokalemia in thyrotoxic periodic paralysis
89. 3 receptors: Gene regulation and genetic circuitry
90. Muscular abnormalities in experimental hypothyroidism of rats with special reference to mounding phenomenon
91. Myopathy in Addison's disease
92. The glucocorticoid receptor
93. Myopathy in Cushing's syndrome
94. Kocher Debre Semelaigne syndrome
95. Dynamic aspects of structural proteins in vertebrate skeletal muscle
96. Neuromuscular complications of acromegaly
97. Pseudohypoparathyroidism and hypocalcemia
98. Skeletal muscle calcium metabolism and contractile force in vitamin D-deficient chicks
99. Intracellular transport of 3,5,3′-triiodo-L-thyronine in rat skeletal myoblasts
100. Parathyroid hormone: Physiology, chemistry, biosynthesis, secretion, metabolism, and mode of action
101. Myopathy associated with pigmentation following adrenalectomy for Cushing's syndrome
102. Thyrotoxic myopathy: A clinical and quantitative analytic electromyographic study
103. Electromyography in thyrotoxicosis
104. Neuromuscular status in hypothyroidism
105. Muscle adipose tissue morphology and metabolism in Cushing's syndrome
106. Thyrotoxic periodic paralysis in caucasians. Report of 8 cases
107. Acute exertional rhabdomyolysis in hypothyroidism: The result of a reversible defect in glycogenolysis?
108. The effect of cortisone on the structure and strength of skeletal muscle
109. Effects of vitamin D and parathormone on muscle: Potential role in uremic myopathy
110. Should dehydroepiandrosterone replacement therapy be provided with glucocorticoids?
111. Changes in the kinetics of muscle contraction in vitamin D depleted rats
112. Muscle function in rheumatic disease patients treated with corticosteroids
113. Acute illness myopathy
114. Endocrine myopathies (hyper- and hypofunction of adrenal, thyroid, pituitary and parathyroid glands and iatrogenic steroid myopathy)
115. Disorders of muscle: The periodic paralyses
116. Slow sodium channel inactivation in mammalian muscle: A possible role in regulating excitability
117. Endocrine Myopathies
118. A case of Graves' disease associated with polymyositis
119. Periodic paralysis in hyperthyroidism
120. Myopathy in thyrotoxicosis: With special emphasis on an effect of potassium ingestion on serum and urinary creatine
121. Mutations of signal-tranducing G proteins in human disease
122. A rapid, extranuclear effect of 3,5,3,′-triiodothyronine on sugar uptake by several tissues in the rat in vivo. Evidence for a physiological role for the thyroid hormone action at the level of the plasma membrane
123. Risk factors for hydrocortisone myopathy in acute severe asthma
124. Role of glucocorticoids in increased muscle glutamine production in starvation
125. Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism
126. Hyperkalemic paralysis, neuropathy, and persistent motor neuron discharges at rest in Addison's disease
127. Lung function and respiratory muscle strength after propranolol in thyrotoxicosis
128. Eyeing up Graves ophthalmopathy
129. New concepts in regulation and function of the insulin growth factors: Implications for understanding normal growth and neoplasia
130. Muscle histology of hypocalcemic myopathy in hypoparathyroidism
131. Postoperative tetany in Graves disease: Important role of vitamin D metabolites
132. Analysis of muscle weakness in osteomalacia